- Home
- Publications
- Publication Search
- Publication Details
Title
The Emerging Role of Neutrophil Granulocytes in Multiple Sclerosis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 7, Issue 12, Pages 511
Publisher
MDPI AG
Online
2018-12-03
DOI
10.3390/jcm7120511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions
- (2018) Maximilien Evrard et al. IMMUNITY
- Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity
- (2018) Maren Lindner et al. JOURNAL OF NEUROCHEMISTRY
- Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
- (2018) Ivana Bjelobaba et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
- (2018) Amit Bar-Or et al. NEUROLOGY
- Inhibition of myeloperoxidase by N-acetyl lysyltyrosylcysteine amide reduces experimental autoimmune encephalomyelitis-induced injury and promotes oligodendrocyte regeneration and neurogenesis in a murine model of progressive multiple sclerosis
- (2018) Guoliang Yu et al. NEUROREPORT
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe neutropenia after rituximab-treatment of multiple sclerosis
- (2018) Eero Rissanen et al. Multiple Sclerosis and Related Disorders
- Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
- (2017) Aiden Haghikia et al. LANCET NEUROLOGY
- Neutrophil granulocytes in cerebral ischemia – Evolution from killers to key players
- (2017) Jan-Kolja Strecker et al. NEUROCHEMISTRY INTERNATIONAL
- Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients
- (2017) Tatiana Plavina et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and −3 signaling in glia
- (2017) Ye-Hyeon Ahn et al. Scientific Reports
- Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab
- (2017) María Inés Gaitán et al. JAMA Neurology
- Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment
- (2017) David Baker et al. Multiple Sclerosis and Related Disorders
- The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis
- (2017) AK Bisgaard et al. Multiple Sclerosis and Related Disorders
- Neutrophil heterogeneity: implications for homeostasis and pathogenesis
- (2016) C. Silvestre-Roig et al. BLOOD
- The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy
- (2016) Martina Ahlmann et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pondering neutrophil extracellular traps with healthy skepticism
- (2016) William M. Nauseef et al. CELLULAR MICROBIOLOGY
- Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
- (2016) Luke Healy et al. CURRENT DRUG TARGETS
- Dimethylfumarate Impairs Neutrophil Functions
- (2016) Susen Müller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association between adverse perinatal outcomes and amino acid levels measured with nutrient questionnaire in adolescent pregnancies
- (2016) Ali Irfan Guzel et al. Journal of the Chinese Medical Association
- The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis
- (2015) Seden Demirci et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Interleukin-17 and innate immunity in infections and chronic inflammation
- (2015) Natasa Isailovic et al. JOURNAL OF AUTOIMMUNITY
- Neutrophil-related factors as biomarkers in EAE and MS
- (2015) Julie M. Rumble et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype
- (2015) Yudong Liu et al. JOURNAL OF IMMUNOLOGY
- Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood-brain barrier integrity and ameliorates disease severity
- (2015) Hao Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice
- (2015) Bo Young Choi et al. Journal of Neuroinflammation
- Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica
- (2015) Laura Hertwig et al. Multiple Sclerosis Journal
- Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
- (2015) Elena Zenaro et al. NATURE MEDICINE
- Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
- (2015) A. Warnatsch et al. SCIENCE
- Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica
- (2015) Laura Hertwig et al. Multiple Sclerosis Journal
- Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data
- (2015) Valeria Allizond et al. PLoS One
- Neutrophils Mediate Blood–Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases
- (2014) Benoit Aubé et al. JOURNAL OF IMMUNOLOGY
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- IL-17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis
- (2014) M. Kostic et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients
- (2014) Francesca Sangalli et al. Multiple Sclerosis and Related Disorders
- How Natalizumab Binds and Antagonizes α4Integrins
- (2013) Yamei Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs
- (2013) K. Steinbach et al. JOURNAL OF IMMUNOLOGY
- Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
- (2013) Timm Oberwahrenbrock et al. Multiple Sclerosis Journal
- Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial
- (2013) Patrick Vermersch et al. Multiple Sclerosis Journal
- Neutrophil Function: From Mechanisms to Disease
- (2012) Borko Amulic et al. Annual Review of Immunology
- Intravascular Neutrophil Extracellular Traps Capture Bacteria from the Bloodstream during Sepsis
- (2012) Braedon McDonald et al. Cell Host & Microbe
- Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
- (2012) Christian Confavreux et al. Multiple Sclerosis Journal
- Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein
- (2012) Katja Herges et al. Multiple Sclerosis Journal
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones
- (2012) Mona Saffarzadeh et al. PLoS One
- Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain
- (2011) Samira Saadoun et al. ANNALS OF NEUROLOGY
- A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
- (2011) Janesh Pillay et al. JOURNAL OF CLINICAL INVESTIGATION
- Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease
- (2011) M. Ioannou et al. JOURNAL OF IMMUNOLOGY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Neutrophils in multiple sclerosis are characterized by a primed phenotype
- (2011) Matthias Naegele et al. JOURNAL OF NEUROIMMUNOLOGY
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mouse models for multiple sclerosis: Historical facts and future implications
- (2010) Andrew L. Croxford et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days
- (2010) J. Pillay et al. BLOOD
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
- (2010) Venizelos Papayannopoulos et al. JOURNAL OF CELL BIOLOGY
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
- (2010) Pingxin Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS
- (2010) E. Kingwell et al. NEUROLOGY
- Younger children with MS have a distinct CSF inflammatory profile at disease onset
- (2010) D. Chabas et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
- (2010) A. Hakkim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular DNA traps promote thrombosis
- (2010) T. A. Fuchs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation
- (2009) Yanming Wang et al. JOURNAL OF CELL BIOLOGY
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps
- (2009) A. B. Guimaraes-Costa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Murine neutrophils present Class II restricted antigen
- (2008) Shauna Culshaw et al. IMMUNOLOGY LETTERS
- The Th17–ELR+CXC chemokine pathway is essential for the development of central nervous system autoimmune disease
- (2008) Thaddeus Carlson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis
- (2008) T Vollmer et al. Multiple Sclerosis Journal
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia
- (2008) S. Demko et al. ONCOLOGIST
- Neutrophil extracellular traps are induced by Mycobacterium tuberculosis
- (2008) Victoria Ramos-Kichik et al. TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now